Protara Therapeutics Inc Share Price

NASDAQ: TARA

Small Cap

$3.13

-0.07

(-2.19%)

as on September 13, 2025 at 1:29 am IST

$₹

Protara Therapeutics Inc Stock Performance

as on September 13, 2025 at 1:29 am IST

Day's Low
Day's High
$3.12
Day's Price Range
$3.24
$3.13
0.32%
Downside
3.51%
Upside
52 Week's Low
52 Week's High
$1.6
52-Week Price Range
$10.48
$3.13
49.04%
Downside
234.82%
Upside

Protara Therapeutics Inc share price movements today

Previous Close: $3.20
Open: $3.19
Volume: 322.8K
Day's Low - High: $3.12 - $3.24
52 Week Low - High: $1.6 - $10.48

Protara Therapeutics Inc Historical Returns

1 Month Return: + 4.23 %
3 Month Return: -1.84 %
1 Year Return: + 84.97 %
3 Year Return: -23.63 %
5 Year Return: -81.56 %

Protara Therapeutics Inc Stock Fundamentals & Key Indicators

Check Protara Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$123.5M

EPS (TTM)

-1.48

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-57.0M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

367600.00%

Protara Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Protara Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Protara Therapeutics Inc	BUY	$123.5M	-81.56%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.5B	282.7%	-505.15	-12.96%
Beone Medicines Ltd	NA	$37.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.9B	54.04%	28.24	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.2B	2.03%	14.33	31.37%

Stock Returns calculator for Protara Therapeutics Inc Stock including INR - Dollar returns

The Protara Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Protara Therapeutics Inc investment value today

Current value as on today

₹1,86,040

Returns

₹86,040

(+86.04%)

Returns from Protara Therapeutics Inc Stock

₹80,925 (+80.92%)

Dollar Returns*

₹5,115 (+5.12%)

Analyst Recommendation on Protara Therapeutics Inc Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Protara Therapeutics Inc. Average target price of $24.2

Protara Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Protara Therapeutics Inc.

What analysts predicted

87.07%UPSIDE

Target Price

$24.2

Current Price

$3.13

Analyzed by

11 Analysts

Target

$24.20

Protara Therapeutics Inc target price $24.2, a slight upside of 87.07% compared to current price of $3.13. According to 11 analysts rating.

Protara Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Protara Therapeutics Inc Stock has decreased by -53% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 14, 2025 to September 13, 2025

Change:-53% versus previous 30 day period

Protara Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	1	-	-	-	0	-	-
Gross Profit	0	0	0	1	0	0	0	0	0	0
Operating Income	-9	-12	-10	-11	-11	-10	-12	-14	-14	-16
EBITDA	-9	-12	-10	-10	-11	-10	-12	-14	-14	-16
Interest Expense	0	-	-	0	-	-	-	-	1	1
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-9	-11	-9	-10	-11	-9	-11	-12	-11	-14
Income Tax Expense	0	0	0	1	0	-	-	-	-	-
Net Income	-8	-11	-9	-10	-11	-9	-11	-12	-11	-14
Net Profit Margin	0.00%	0.00%	0.00%	-846.11%	0.00%	0.00%	0.00%	-3846.08%	0.00%	0.00%

Protara Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-
Gross Profit	0	0	-1	0	0	0
Operating Income	-15	-34	-47	-67	-43	-49
EBITDA	-7	-33	-46	-64	-43	-49
Interest Expense	-	0	1	1	-	4
Depreciation	0	0	0	0	0	0
Income Before Tax	-14	-33	-47	-65	-40	-44
Income Tax Expense	0	0	0	-1	0	-
Net Income	-14	-33	-47	-65	-40	-44
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Protara Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-11	-9	-10	-11	-9	-11	-12	-11	-14
Operating Cash Flow	-9	0	-8	-10	-7	-8	-9	-14	-12
Investing Cash Flow	22	6	14	23	2	-29	22	-58	-47
Financing Cash Flow	0	0	0	0	42	-	97	1	0
Change in Cash	12	0	5	12	37	-37	111	-71	-59

Protara Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-28	-29	-20	-14	-33	-47	-65	-40	-44
Operating Cash Flow	-23	-22	-23	-15	-23	-34	-26	-37	-35
Investing Cash Flow	19	-16	18	2	2	-98	14	53	19
Financing Cash Flow	0	23	2	0	189	0	0	0	139
Change in Cash	-3	-15	-1	-13	168	-132	-11	15	123

Global Institutional Holdings in Protara Therapeutics Inc

Funds	Holdings
HHG PLC	9.82%
RA Capital Management, LLC	8.81%
Blackstone Inc	4.52%
Opaleye Management Inc	4.48%
Velan Capital Investment Management LP	4.32%

See all

Insights on Protara Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 126.8% return, outperforming this stock by 152.0%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 76.6% return, outperforming this stock by 6.7%
NEGATIVE IMPACT
Price Dip
In the last 6 months, TARA stock has moved down by -20.5%

About Protara Therapeutics Inc

protara therapeutics, inc., a clinical-stage company, engages in the identifying and advancing transformative therapies for people with rare and specialty diseases. the company's lead program is tara-002, an investigational cell therapy for the treatment of lymphatic malformations. it also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. the company was formerly known as artara therapeutics, inc. and changed its name to protara therapeutics, inc. in may 2020. protara therapeutics, inc. is based in new york, new york.

Organisation	Protara Therapeutics Inc
Headquarters	345 Park Avenue South, New York, NY, United States, 10010
Industry	Health Technology
CEO	Mr. Jesse Shefferman
E-voting on shares	Click here to vote

Key Management of Protara Therapeutics Inc

Name	Title
Ms. Justine O'Malley	Senior Vice President of Investor Relations & Corporate Affairs
Ms. Mary J. Grendell J.D.	General Counsel & Corporate Secretary
Dr. Leonardo Viana Nicacio M.D.	Chief Medical Officer
Mr. William Conkling	Chief Commercial Officer
Mr. Jesse Shefferman	Co-founder, CEO, President & Director
Dr. Jacqueline Zummo M.B.A., M.P.H., Ph.D.	Co-Founder & Chief Scientific Operations Officer
Mr. Patrick Fabbio M.B.A.	Chief Financial Officer
Ms. Hannah Fry	VP, Principal Accounting Officer & Controller
Dr. Shane Williams Ph.D.	Chief People Officer

FAQs

What is Protara Therapeutics Inc share price today?

Protara Therapeutics Inc share price today is $3.13 as on September 13, 2025 at 1:29 am IST at the close of the market. Protara Therapeutics Inc share today touched a day high of $3.24 and a low of $3.12.

What is the 52 week high and 52 week low for Protara Therapeutics Inc share?

Protara Therapeutics Inc share touched a 52 week high of $10.48 on December 5, 2024 and a 52 week low of $1.6 on October 10, 2024. Protara Therapeutics Inc stock price today i.e. September 13, 2025 at 1:29 am IST is closed at $3.13,which is 70.13% down from its 52 week high and 96.24% up from its 52 week low.

What is Protara Therapeutics Inc's market capitalisation today?

Protara Therapeutics Inc market capitalisation is $0.00T as on September 13, 2025 at 1:29 am IST.

How to invest in Protara Therapeutics Inc Stock (TARA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Protara Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Protara Therapeutics Inc Shares that will get you 0.4792 shares as per Protara Therapeutics Inc share price of $3.13 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Protara Therapeutics Inc Stock (TARA) from India?

Indian investors can start investing in Protara Therapeutics Inc (TARA) shares with as little as ₹88.25 or $1 (as of September 13, 2025 at 6:43 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.50 in Protara Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 13, 2025 at 6:43 am IST). Based on Protara Therapeutics Inc share’s latest price of $3.13 as on September 13, 2025 at 1:29 am IST, you will get 3.1949 shares of Protara Therapeutics Inc. Learn more about fractional shares .

What are the returns that Protara Therapeutics Inc has given to Indian investors in the last 5 years?

Protara Therapeutics Inc stock has given -81.56% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?